Barnes Retina Institute
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Barnes Retina Institute sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).
Barnes Retina Institute: 6 sponsored US clinical trials, none currently recruiting.
Barnes Retina Institute sponsors 6 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 4 completed. 0 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Retinal Vein Occlusion, with 1 trials.
Upper-quartile sponsor footprint
Barnes Retina Institute sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
6 total, page 1 of 1
Bevacizumab Versus Ranibizumab in Treatment of Macular Edema From Vein Occlusion
NCT01428388
Dexamethasone Intravitreal Implant After Vitrectomy For Epiretinal Membrane
NCT01410201
Anatomic Outcomes Following Ozurdex Injections
NCT01282411
Posterior Vitreous Detachment (PVD) Assessment During Dual Retinal Vein Occlusion (RVO) Lucentis Evaluations
NCT00831350
Comparison of Scheimpflug Photos of the Crystalline Lens in Patients Who Have Undergone Vitrectomy Surgery and Controls
NCT00406263
Macugen for Histoplasmosis
NCT00272766
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Therapeutic Areas
How the Barnes Retina Institute early-phase archive is shaped
6 indexed studies, none listed as recruiting (0% open); 4 completed (67%).
Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).
Top condition: Retinal Vein Occlusion (1 trial), 1 other listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Barnes Retina Institute: archived-pipeline peers nationwide
Peers matched on 6 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Barnes Retina Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 6 archived trials
- 23andMe · 6 trials · 0% recruiting
- Aardvark Therapeutics · 6 trials · 0% recruiting
- Abbisko Therapeutics Co · 6 trials · 67% recruiting
- AbGenomics B.V Taiwan Branch · 6 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
- 3 Waves Wellness · 0% recruiting · 2 trials
Related
What to do with this Barnes Retina Institute page
6 registered trials is a research-attention snapshot, not an endorsement of Barnes Retina Institute or any single study.
- None of Barnes Retina Institute's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Retinal Vein Occlusion is the condition Barnes Retina Institute studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Retinal Vein Occlusion trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Barnes Retina Institute pipeline card: 6 registered trials from official public datasets.Report a data error.